Haplotype | Group | Chi-square (X2) | P value | Risk | ||
---|---|---|---|---|---|---|
GDM | Control | OR | 95% CI | |||
II + MM + GG | 0 (0.0%) | 50 (100.0%) | 32.879 | 0.001* | 2.400 | 1.229–4.688 |
II + MM + AA | 4 (100.0%) | 0 (0.0%) | 2.424 | 0.119 | 1.714 | 1.063–2.765 |
II + MT + GG | 0 (0.0%) | 10 (100.0%) | 8.556 | 0.003* | 2.400 | 1.229–4.688 |
II + MT + GA | 0 (0.0%) | 10 (100.0%) | 8.556 | 0.003* | 2.400 | 1.229–4.688 |
II + TT + GG | 0 (0.0%) | 5 (100.0%) | 4.958 | 0.026* | 2.400 | 1.229–4.688 |
II + TT + GA | 3 (100.0%) | 0 (0.0%) | 1.875 | 0.171 | 1.714 | 1.063–2.765 |
II + TT + AA | 1 (16.7%) | 5 (83.3%) | 2.812 | 0.094 | 0.143 | 0.013–1.630 |
ID + MM + GG | 1 (6.2%) | 15 (93.8%) | 9.115 | 0.003* | 0.048 | 0.005–0.488 |
ID + MM + GA | 8 (28.6%) | 20 (71.4%) | 3.175 | 0.075 | 0.286 | 0.070–1.171 |
ID + MM + AA | 3 (37.5%) | 5 (62.5%) | 0.833 | 0.361 | 0.429 | 0.068–2.684 |
ID + MT + GG | 7 (58.3%) | 5 (41.7%) | 0.001 | 1.000 | 1.000 | 0.197–5.068 |
ID + MT + GA | 24 (82.8%) | 5 (17.2%) | 2.746 | 0.098 | 3.429 | 0.766–15.342 |
ID + MT + AA | 13 (100.0%) | 0 (0.0%) | 6.771 | 0.009* | 1.714 | 1.063–2.765 |
ID + TT + GG | 1 (100.0%) | 0 (0.0%) | 0.677 | 0.411 | 1.714 | 1.063–2.765 |
ID + TT + GA | 5 (100.0%) | 0 (0.0%) | 2.951 | 0.086 | 1.714 | 1.063–2.765 |
ID + TT + AA | 6 (100.0%) | 0 (0.0%) | 3.462 | 0.063 | 1.714 | 1.063–2.765 |
DD + MM + GA | 4 (16.7%) | 20 (83.3%) | 6.545 | 0.011* | 0.143 | 0.030–0.688 |
DD + MM + AA | 0 (0.0%) | 5 (100.0%) | 4.958 | 0.026* | 2.400 | 1.229–4.688 |
DD + MT + GG | 11 (100.0%) | 0 (0.0%) | 5.856 | 0.016* | 1.714 | 1.063–2.765 |
DD + MT + GA | 9 (100.0%) | 0 (0.0%) | 4.922 | 0.027* | 1.714 | 1.063–2.765 |
DD + MT + AA | 28 (100.0%) | 0 (0.0%) | 13.333 | 0.001* | 1.714 | 1.063–2.765 |
DD + TT + GG | 10 (66.7%) | 5 (33.3%) | 0.199 | 0.656 | 1.429 | 0.297–6.877 |
DD + TT + GA | 15 (100.0%) | 0 (0.0%) | 7.670 | 0.006* | 1.714 | 1.063–2.765 |
DD + TT + AA | 7 (58.3%) | 5 (41.7%) | Reference |